Managing non-proportionality of hazards (PH) within TNT: a randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced triple negative (TN) or brca1/2 breast cancer (BC)

Detalles Bibliográficos
Autores principales: Tovey, Holly, Bliss, Judith, Tutt, Andrew, Morden, James, Jarman, Katy, Martin, Sue, Kernaghan, Sarah, Toms, Christy, Kilburn, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660070/
http://dx.doi.org/10.1186/1745-6215-16-S2-P150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660070/
http://dx.doi.org/10.1186/1745-6215-16-S2-P150

Ejemplares similares